Document is current
Any future updates will be listed below
-
Authors
Dierl, Alexander https://orcid.org/0009-0002-9464-0262
Hinsen, Maximilian https://orcid.org/0000-0003-3545-8196
Wild, Eva-Maria https://orcid.org/0009-0003-9399-2108
Bayerl, Nadine https://orcid.org/0000-0002-8530-6783
Heiss, Rafael https://orcid.org/0000-0002-2897-5411
Nagel, Armin M. https://orcid.org/0000-0003-0948-1421
Schmidt, Sandy
Grimm, Robert
Vogel-Claussen, Jens
Voskrebenzev, Andreas
Naumann-Bartsch, Nora https://orcid.org/0000-0001-5606-9822
Anderheiden, Felix
Huber, Felix
Mueller, Nicolas
Schoeffl, Isabelle
Woelfle, Joachim
Uder, Michael
Regensburger, Adrian P. https://orcid.org/0000-0001-8244-1261
Knieling, Ferdinand https://orcid.org/0000-0002-3535-2626
Karow, Axel
- License Information
-
More Information
Article History
Received: 11 July 2025
Accepted: 23 December 2025
First Online: 22 January 2026
Competing interests
: M.H., M.U., and R.H. are part of the speakers’ bureau of Siemens Healthineers GmbH. R.G. is an employee of Siemens Healthineers (Erlangen, Germany). J.VC. and A.V. are shareholders in BioVisioneers GmbH, a company with an interest in pulmonary MRI methods. F.K. is a member of the advisory board of iThera Medical GmbH, Munich, Germany, received travel support from iThera Medical GmbH, Germany, UCB Pharma, Germany and Sanofi Aventis, Germany. F.K. reports lecture fees from Sanofi Aventis, Germany and Siemens Healthcare GmbH, Germany. A.P.R. received travel support from iThera Medical GmbH, Germany and Sanofi Aventis, Germany. N.B. is supported by the IZKF Clinician Scientist Program and the IZKF Laboratory Rotation Program of the Medical Faculty of the Friedrich-Alexander-Universität Erlangen-Nürnberg.All other authors declare no competing interest.
